netFormulary South East London Joint Medicines Formulary NHS
Guy's and St Thomas' NHS Foundation Trust
Kings College Hospital NHS Foundation Trust
Lewisham and Greenwich NHS Trust
 
 Search
 Formulary Chapter 11: Eye - Full Chapter
Notes:

Where a formulary entry does not detail a medicine’s indications for use, the medicine can be assumed to be approved for all licensed indications.

Formulary approved "off-label" use is detailed separately.

 Details...
11.04.01  Expand sub section  Corticosteroids
Betamethasone 0.1% & neomycin 0.5% eye drops & ointment
View adult BNF View SPC online
Formulary  
   
Betamethasone 0.1% eye drops & ointment
View adult BNF View SPC online
Formulary  
   
Dexamethasone eye drops 0.1%
View adult BNF View SPC online
Formulary Preservative-free eye drops available on request 
   
Dexamethasone injection (intracameral use - off-label)
View adult BNF View SPC online
Formulary
Red

Approved off-label indication:

Intracameral use in Endoscopic Cyclophotocoagulation (ECP) and cataract surgery where there is increased inflammation

Dose: 0.4mg peri-operatively

Only the Hospira AMPOULE (preservative free) formulation is approved for use in this indication

 
   
Fluorometholone eye drops 0.1% (FML)
View adult BNF View SPC online
Formulary  
   
Loteprednol eye drops 0.5%
View adult BNF View SPC online
Formulary

Treatment of post-operative inflammation following ocular surgery

Approved off-label indication:

Control of intraocular inflammation in patients with uveitis where the patient is known to be or becomes a steroid responder

 
   
Maxitrol eye drops
View adult BNF View SPC online
Formulary Contains:
  • Dexamethasone 0.1%
  • Hypromellose 0.5%
  • Neomycin 0.35%
  • Polymyxin B sulphate 6000 units/ml 
  •    
    Maxitrol eye ointment
    View adult BNF View SPC online
    Formulary Contains:
  • Dexamethasone 0.1%
  • Neomycin 0.35%
  • Polymyxin B sulphate 6000 units/g  
  •    
    Prednisolone eye drops 0.5%, 1%
    View adult BNF View SPC online
    Formulary Preservative-free eye drops 0.5% available on request 
       
    Sofradex eye drops
    View adult BNF View SPC online
    Formulary Contains:
  • Dexamethasone 0.05%
  • Framycetin sulphate 0.5%
  • Gramicidin 0.005%  
  •    
    Triamcinolone injection (Intracinol ophthalmic suspension 40 mg in 1mL)
    (Medical device)
    Formulary
    Red

    Approved for:

    • Opacification of the vitreous in eye surgery
    • Treatment and prevenetion of macular oedema in inflammatory eye conditions (off-label)

     Dosing:

    • 4mg (0.1mL) if given intravitreally
    • up to 40 mg (1mL) if given sub-Tenon's/orbital floor
     
       
     ....
    Key
    note Notes
    Section Title Section Title (top level)
    Section Title Section Title (sub level)
    First Choice Item First Choice item
    Non Formulary Item Non Formulary section
    Restricted Drug
    Restricted Drug
    Unlicensed Drug
    Unlicensed
    Track Changes
    Display tracking information
    click to search medicines.org.uk
    Link to adult BNF
    click to search medicines.org.uk
    Link to SPCs
    SMC
    Scottish Medicines Consortium
    Cytotoxic Drug
    Cytotoxic Drug
    CD
    Controlled Drug
    High Cost Medicine
    High Cost Medicine
    Cancer Drugs Fund
    Cancer Drugs Fund
    NHSE
    NHS England
    Homecare
    Homecare
    CCG
    CCG

    Traffic Light Status Information

    Status Description

    Red

    Specialist or hospital prescribing only. The responsibility for prescribing, monitoring, dose adjustment and review should remain with the specialist or hospital. In very exceptional circumstances a specialist may discuss individual patient need for a RED drug to be prescribed by a GP and the GP should consider informing the Medicines Management team before a decision is made to prescribe for individual patients.   

    Amber 1

    Treatment can be initiated in primary care after a recommendation from an appropriate specialist  

    Amber 2

    Specialist initiation followed by maintenance prescribing in primary care  

    Amber 3

    Specialist initiation with ongoing monitoring required. After dose stabilisation GPs can be requested to take over prescribing responsibilities using the approved APC shared care documentation  

    Green

    Specialist and non-specialist initiation  

    Grey

    Not recommended for prescribing  

    netFormulary